Clinical characteristics of the 86 patients analyzed by RQ-PCR
Characteristic . | Data . |
|---|---|
| Age, y | 51 |
| Median range, y | 28-66 |
| Older than 60 y, no. (%) | 13 (15) |
| Male, no. (%) | 55 (64) |
| Disease stage at diagnosis, no. (%) | |
| I | 1 (1) |
| II | 5 (6) |
| III | 24 (28) |
| IV | 56 (65) |
| BM involvement, no. (%) | 55 (64) |
| Extranodal sites other than BM, no. (%) | |
| 1 | 17 (20) |
| 2 or more | 3 (3) |
| B symptoms, no. (%) | 8 (9) |
| Bulky disease, no. (%)* | 15 (17) |
| Serum LDH level, no. (%) | |
| Normal | 73 (85) |
| Elevated | 10 (12) |
| International prognostic index, no. (%) | |
| 0-1 | 56 (65) |
| 2 or higher | 28 (33) |
| Unknown | 2 (2) |
| Response to CHOP chemotherapy, no. (%) | |
| Complete | 51 (59) |
| Partial | 28 (32) |
| No response | 7 (8) |
| Rituximab treatment, no. (%)† | |
| Yes | 49 (57) |
| No | 37 (43) |
Characteristic . | Data . |
|---|---|
| Age, y | 51 |
| Median range, y | 28-66 |
| Older than 60 y, no. (%) | 13 (15) |
| Male, no. (%) | 55 (64) |
| Disease stage at diagnosis, no. (%) | |
| I | 1 (1) |
| II | 5 (6) |
| III | 24 (28) |
| IV | 56 (65) |
| BM involvement, no. (%) | 55 (64) |
| Extranodal sites other than BM, no. (%) | |
| 1 | 17 (20) |
| 2 or more | 3 (3) |
| B symptoms, no. (%) | 8 (9) |
| Bulky disease, no. (%)* | 15 (17) |
| Serum LDH level, no. (%) | |
| Normal | 73 (85) |
| Elevated | 10 (12) |
| International prognostic index, no. (%) | |
| 0-1 | 56 (65) |
| 2 or higher | 28 (33) |
| Unknown | 2 (2) |
| Response to CHOP chemotherapy, no. (%) | |
| Complete | 51 (59) |
| Partial | 28 (32) |
| No response | 7 (8) |
| Rituximab treatment, no. (%)† | |
| Yes | 49 (57) |
| No | 37 (43) |